Skip to content
Checked.be
Complete company report
Generated 03-09-2026
Active BE 0457.997.178Private limited company

I.L.T.-PHARMA

Schoondreef 18 ·2330 Merksplas, Belgium· 30 yrs active
Sector: Sanitaire werkzaamheden (43221)
Conclusion Checked

I.L.T.-PHARMA has been active since 1996 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €940k and a net result of €231k. The computed 12-month bankruptcy probability is 0.7% (low).

Based on the State Gazette, CBE and 2 annual accounts.
Key figures
Equity €940k
Net result €231k
Active 30 yrs
Locations 1
Financial profile 5 of 5 axes measured · computed by Checked
Health69Profitability100Solvency53Growth78Stability100
80 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 69
Profitability 100
Solvency 53
Growth 78
Stability 100
Bankruptcy probability (12 mo) Checked model v1 · free
0.7% Low
0%0,5%1,5%4%10%≥25%
Higher-failure-rate sector +Long track record −

How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
Long-established
Founded in 1996, 30 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score FY 2025 · computed
69 / 100 Healthy
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview29 NBB filings
Annual accounts filed on 16-12-2025 with the NBB · fiscal year 2025 · abbreviated schema
€0€200k€400kOperating result 2024: €39k€39kNet result 2024: €2k€2kOperating result 2025: €458k€458kNet result 2025: €231k€231k20242025
Operating resultNet result
EBITDA
€523k
+357.7% 24-25
Net profit
€231k
+14591.5% 24-25
Cash flow
€295k
+285.9% 24-25
Total assets
€2.78M
-21.3% 24-25
Equity
€940k
+32.5% 24-25
Working capital
€-22k
+91.3% 24-25
Employees (FTE)
0
- 24-25
Income taxes
€78k
+23636.7% 24-25
Dividends
€0
-100.0% 24-25
Debt
€1.84M
-34.8% 24-25
Debt ≤ 1y
€1.20M
-43.2% 24-25
Debt > 1y
€602k
-15.4% 24-25
Current ratio
0.98
+11.3% 24-25
Quick ratio
0.63
+299.1% 24-25
Solvency
33.8%
+68.3% 24-25
Debt / equity
1.96
-50.8% 24-25
ROE
24.5%
+10986.1% 24-25
ROA
8.3%
+18556.6% 24-25
Interest coverage
3.49
+24.9% 24-25
Figures by fiscal year and ratios
Fiscal year2025
Depositabbreviated schema
Revenue-
EBITDA€523k
Net profit€231k
Cash flow€295k
Staff costs-
Income taxes€78k
Dividends€0
Total assets€2.78M
Equity€940k
Debt€1.84M
of which ≤ 1y€1.20M
of which > 1y€602k
Working capital€-22k
Employees (FTE)0.0
Ratios (computed)
2025
Current ratio0.98
Quick ratio0.63
Working capital ratio-0.8%
Solvency33.8%
Debt / equity1.96
Long-term debt ratio0.64
Interest coverage3.49
Gross margin-
Net margin-
ROA8.3%
ROE24.5%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts (25 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€2.78M
Fixed assets 21/28€1.61M
Tangible fixed assets 22/27€1.61M
Financial fixed assets 28€0
Current assets 29/58€1.17M
Stocks & contracts in progress 3€417k
Amounts receivable within one year 40/41€89k
Cash & bank 54/58€667k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€2.78M
Equity 10/15€940k
Contributions / capital 10/11€317k
Reserves 13€623k
Accumulated profits (losses) 14€0
Amounts payable 17/49€1.84M
Amounts payable after one year 17€602k
Amounts payable within one year 42/48€1.20M
Trade debts payable within one year 44€703
Income statement
Gross operating margin 9900€537k
Operating result 9901€458k
Financial income 75€381
Financial charges 65€150k
Result before taxes 9903€309k
Income taxes 67/77€78k
Net result for the period 9904€231k
Result to be appropriated 9905€117k
This table shows the latest fiscal year. 1 prior year, with figures and ratios, belongs to a paid plan. See plans →
Ratios computed by Checked.
Legal Structure
NACE primary Sanitaire werkzaamheden(43221)
Legal form Private limited company(610)
Incorporation03-06-1996
StatusActive
Postal code2330
Establishment units 1 location
I.L.T.-Pharma
Schoondreef 18, 2330 Merksplashet bouwen van koelkamers, kluizen, enz.
since 19962.076.820.775
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
13023E0058/00H002 Flanders 2,438 m² 1 · 218 m² 10.1 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 10 events
2025
16-12-2025 NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2024
13-12-2024 NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
22-01-2024 NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2022
23-12-2022 NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2021
24-12-2021 NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2020
24-12-2020 NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2019
23-12-2019 NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
21-12-2018 NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
21-12-2017 NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2016
22-12-2016 NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Belgian State Gazette reading coverage 0 of 7 acts read

We know of 7 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Credit advice verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
Company registry (CBE) Crossroads Bank
Activities
Sanitaire werkzaamheden43221Overig loodgieterswerk45332Holdings64200Activiteiten van holdings64210Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220Verhuur van overige machines en werktuigen, n.e.g.71340Overige adviesbureaus op het gebied van bedrijfsvoering en beheer74142Managementactiviteiten van holdings74151Verhuur en lease van andere machines en werktuigen en andere materiële goederen77399
Primary activity highlighted.
Names & trade names
Legal nameNL I.L.T.-PHARMA
Registered office
Schoondreef 18
2330 Merksplas, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same sector and region · no size comparison possible · 972 of 7,014 with filed accounts
Aerts Ronald Technics BE 0700.506.383 · Merksplas
Airco Stappers BE 0771.887.101 · Merksplas
ARGE Construct BE 1034.636.048 · Merksplas
Gimax BE 0743.391.568 · Merksplas
HUYBRECHTS BART LOODGIETERIJ BE 0891.188.884 · Merksplas
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative